News

Please click here to see the latest news stories relating to Covid-19
 
 

Bionow members are welcome to submit PR items to this newsroom for all to see. Describing current activity and progress in the sector, it's a great place to promote your orgnaisation and keep up to date with the latest developments.

Whether currently a member or not, also keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Sygnature has significantly expanded our DMPK capabilities and expertise with the acquisition of XenoGesis, the UK’s largest independent laboratory-based CRO specialising in pre-clinical D...

Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities

Peak Proteins is a contract research organisation providing protein production and structure determination services. We chat to CEO of Peak Proteins, Dr. Mark Abbott.

F2G Ltd, a UK- and Austria-based biotech developing novel therapies for life-threatening systemic fungal infections, announced today that following the granting of Breakthrough Therapy desig...

Biorelate, a UK-based AI start up, is offering all researchers free use of Galactic, its cloud-based web tool, to support biomedical research while lab access is restricted around the world.

Medicines Discovery Catapult, Retrogenix and Peak Proteins announce a collaboration to advance understanding of the cellular mechanisms of infection by COVID-19.

Dr Tomas Adomavicius joins Peak Proteins as a Protein Purification Expert. Tomas graduated from Vilnius University in Lithuania before coming to the UK to continue his studies.

A new global collaboration of philanthropic, non-profit and private sector organizations will work together to accelerate the development of novel TB treatment regimens for all TB patients.

Collaboration to design novel compound libraries with the maximum pharmacological diversity within the smallest library size.

Limited number of computational chemistry consultancy sessions for start-ups and small to medium sized enterprises (SMEs) and academics working on drug discovery projects.

Leading pharmaceutical and biotech product development consultancy Boyds has enhanced its clinical and medical affairs services offering following the acquisition of Blue Duck Consulting.

Repositive has made its world-leading directory of preclinical cancer models publicly browsable as the first stage of relaunching its Cancer Models Platform. Accessible via the Repositive we...

Our Valued Sponsors & Partners